be used to fund Human Immunodeficiency Virus (HIV) and Acquired Immune
Deficiency Syndrome (AIDS) Patient Care activities, Patient Care
Networks, Ryan White Consortia, the AIDS Insurance Continuation Project,
and other HIV prevention initiatives.
The funds in Specific Appropriation 476 from the Federal Grants Trust
Fund are contingent upon sufficient state matching funds being
identified to qualify for the federal Ryan White grant award. The
Department of Health and the Department of Corrections shall collaborate
in determining the amount of general revenue funds expended by the
Department of Corrections for AIDS-related activities and services that
qualify as state matching funds for the Ryan White grant.
477 AID TO LOCAL GOVERNMENTS
GRANTS AND AIDS - HOUSING OPPORTUNITIES
FOR PERSONS WITH AIDS (HOPWA)
FROM FEDERAL GRANTS TRUST FUND . . . 7,322,703
478 AID TO LOCAL GOVERNMENTS
CONTRIBUTION TO COUNTY HEALTH UNITS
FROM GENERAL REVENUE FUND . . . . . 16,756,986
FROM GRANTS AND DONATIONS TRUST
FUND . . . . . . . . . . . . . . . 2,194,571
479 OPERATING CAPITAL OUTLAY
FROM GENERAL REVENUE FUND . . . . . 140,894
FROM ADMINISTRATIVE TRUST FUND . . . 15,000
FROM FEDERAL GRANTS TRUST FUND . . . 446,798
FROM PLANNING AND EVALUATION TRUST
FUND . . . . . . . . . . . . . . . 11,606
480 SPECIAL CATEGORIES
CONTRACTED SERVICES
FROM GENERAL REVENUE FUND . . . . . 23,180,033
FROM ADMINISTRATIVE TRUST FUND . . . 245,165
FROM FEDERAL GRANTS TRUST FUND . . . 15,467,229
FROM GRANTS AND DONATIONS TRUST
FUND . . . . . . . . . . . . . . . 3,644,903
FROM PLANNING AND EVALUATION TRUST
FUND . . . . . . . . . . . . . . . 8,312,643
FROM RADIATION PROTECTION TRUST
FUND . . . . . . . . . . . . . . . 1,500
From the funds in Specific Appropriation 480, $5,775,000 in
nonrecurring General Revenue is provided to the Department of Health to
contract with a qualified vendor to conduct a comprehensive feasibility
study of the state's three public health laboratories in Jacksonville,
Miami, and Tampa. The vendor shall evaluate the condition of the current
laboratory system and assess options to relocate, modernize, and
consolidate operations into a centrally located inland facility. The
department shall submit a status report on the study's progress by
December 1, 2026, and a final report by June 30, 2027, to the Governor,
the President of the Senate, and the Speaker of the House of
Representatives.
The feasibility study must include, at a minimum:
1. A full inventory and evaluation of existing laboratory equipment at
the Jacksonville, Miami, and Tampa public health laboratories, including
condition, functionality, and whether the equipment supports current
program needs.
2. An assessment of how well each laboratory's equipment, systems, and
processes support core public health functions such as newborn
screening, infectious disease reporting, and emergency response.
3. A gap analysis identifying any outdated, insufficient, or failing
technologies, equipment, or workflows.
4. An evaluation of options to consolidate laboratory operations into a
single inland hub, including an assessment of risks associated with
keeping laboratories in coastal or flood-prone areas.
5. A record of instances in which environmental hazards associated with
keeping laboratories in coastal or flood-prone areas have impacted
operations at the laboratories since July 1, 2021.
6. An analysis of rental options for consolidating operations into an
existing facility, including size, cost, readiness, biosafety
requirements, and federal compliance standards.
7. Recommendations for relocating, modernizing, or consolidating
laboratory functions to improve efficiency, reduce duplication, and